The role of proton pump inhibitors in acute stress ulcer prophylaxis in mechanically ventilated patients.
This article reviews the use of proton pump inhibitors, other pharmacological therapies, and nonpharmacological therapies for the prevention of acute stress ulcers in critically ill patients.
Ziegler
Amy B
AB
Cardiovascular Surgical Services, Elmhurst Memorial Hospital, Elmhurst, Illinois, USA.
D000208:Acute Disease; D000368:Aged; D000369:Aged, 80 and over; D000897:Anti-Ulcer Agents / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D003422:Critical Care / Q000379:methods*; D017277:Drug Approval; D005260:Female; D005745:Gastric Acidity Determination; D006801:Humans; D006863:Hydrogen-Ion Concentration; D015994:Incidence; D007902:Length of Stay; D008297:Male; D009853:Omeprazole / Q000627:therapeutic use; D018579:Patient Selection; D010437:Peptic Ulcer / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D054328:Proton Pump Inhibitors; D012121:Respiration, Artificial / Q000009:adverse effects*; D012307:Risk Factors; D013315:Stress, Psychological / Q000150:complications*; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration
D000897:Anti-Ulcer Agents; D054328:Proton Pump Inhibitors; D009853:Omeprazole